Hypertonic-saline inhalation improves lung function in infants with cystic fibrosis
Preventive inhalation with hypertonic saline initiated in the first months of life was safe and well tolerated, and resulted in improvements in lung clearance index and weight gain in infants with cystic fibrosis. Additionally, those infants who received hypertonic saline inhalation also showed improvement in body weight. The study is published online November 9, 2018 in the American Journal of Respiratory and Critical Care Medicine.
To continue reading this article
Continue reading your article with a eMediNexus account.